Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi-centre 48-week efficacy and safety study in Thailand

Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi-centre 48-week efficacy and safety study in Thailand

Introduction: Efavirenz (EFV) is commonly used for first-line antiretroviral therapy in children and adolescents with HIV, but is associated with neuropsychiatric and metabolic side effects. Rilpivirine (RPV) is better tolerated, and switching from EFV to RPV in virologically suppressed adults has b...

Full description

Saved in:
Bibliographic Details
Main Authors: Wanatpreeya Phongsamart, Watsamon Jantarabenjakul, Sasitorn Chantaratin, Suvaporn Anugulruengkitt, Piyarat Suntarattiwong, Pakpen Sirikutt, Pope Kosalaraksa, Alan Maleesatharn, Kulkanya Chokephaibulkit
Other Authors: Siriraj Hospital
Format: Article
Published: 2022
Subjects:
Medicine
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/75114
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University

Internet

https://repository.li.mahidol.ac.th/handle/123456789/75114

Similar Items